TFRC and inflammatory bowel disease: In summary, this study provides new evidence on the immune regulation of MSCs to modulate Th cells in IBD, inhibiting Tfh differentiation, promoting the expansion of Tfr, improving the imbalance of the Tfh/Tfr ratio, and reducing the inflammatory response.